Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

may limit after repair

After restoration, of may limit . Test different at matched mean force and duration; rapid recovery only after suppressing , with unchanged molecular damage, would contradict this proposed main limitation.

Stage of verification

  1. Hypothesis published2026-09-25
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Biological function

The biological function description is being prepared

Direction

Lens

Puts the cause in the physical arrangement: what is built where, how stiff it is, and what connects to what.Structure and topology

Kind of knowledge gap

The question is designed to try to disprove the leading explanation.Adversarial gap

A double ring marks the main placement where a group contains several values.

Goal
Согласованность завершения репарации с повторной нагрузкой
Competing hypotheses
1
Published
2026-09-25
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Structural protein

    Dermal collagen I and III triple helices

    Triple-helical structural proteins in dermal fibres that bear mechanical loads

    Hypotheses on this target 1
    Dermal collagen I and III triple helicesLower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Replacement. Hypotheses on this target 0Protection from degradation. Hypotheses on this target 0Function preservation. Hypotheses on this target 11Remodelling. Hypotheses on this target 0Crosslink prevention. Hypotheses on this target 0
    • Lower level
    • Higher level
    • Replacement
    • Protection from degradation
    • Function preservation1
    • Remodelling
    • Crosslink prevention

    What is proposed

    Function preservation

    Reduce the probability of irreversible molecular under repeated

    With whatNot stated in the record

    HowNot stated in the record

    From the recordпосле восстановления коллагена VII переносимость повторного сдвига ограничивают редкие необратимые переходы тройных спиралей дермального коллагена I и III в развёрнутое состояние.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helices
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Skin that has closed after injury may still fail when its layers are repeatedly pulled across one another. The unexpected move is to locate the remaining weakness in individual protein molecules that lose their folded structure and stay damaged between loads, even after the connections between skin layers have been restored. This is a hypothesis generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. Collagen VII repair restores attachments between skin layers while leaving a proposed weakness within deeper .
  2. Uneven loading concentrates force on vulnerable portions of collagen I and III.
  3. Local force triggers rare transitions from folded, load-bearing molecules to persistently unfolded regions.
  4. Unfolded regions remain between loading cycles instead of returning to their earlier state.
  5. Accumulating molecular damage reduces the fibers' ability to carry subsequent loads.
  6. Reducing the chance of is predicted to preserve resistance to repeated loading.
A picture for it

A rope can have its end fastenings repaired while a few overloaded strands keep unraveling each time it is pulled. Sound fastenings would not stop damage accumulating along the rope.

Where the picture breaks: Rope strands do not represent the molecular transitions or active cell contraction proposed here. The picture cannot establish whether unfolded remains damaged or whether that damage controls skin failure.

  1. Master questionstep 01 of 04

    The goal is a treatment that brings the functional condition of middle-aged human skin toward that of young skin.

    Rests on: The supplied goal specifies the population and desired comparison, but does not define which functions would establish success.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Repair must finish in a way that leaves skin ready for another load.

    Rests on: Readiness for repeated loading is selected as one component of youthful skin function.

    Assumption

    The goal does not itself establish that coordinating repair with renewed loading is a limiting factor in middle-aged skin.

  3. Gap questionstep 03 of 04

    If restoring mature , the structures that secure the outer skin layer to the tissue beneath it, to a young reference range does not improve resistance to repeated , meaning forces that slide tissue layers across one another, their proposed role as the main remaining limitation would come into question.S8

    Rests on: The focus on renewed loading becomes a question about the skin' attachments. S8, published in Molecular Therapy in 2009, reported improved resistance to mechanical forces after partial restoration in mice; it does not establish that restoring these attachments to a young range resolves repeated-load failure in middle-aged human skin.

    Supported by literature
  4. Hypothesisstep 04 of 04

    After the attachments are repaired, rare, lasting losses of the , the three-chain twisted structure of collagen I and III, are proposed to limit resistance to repeated loading. Uneven forces in the , the supporting skin layer beneath the outer layer, would leave some molecules unfolded between cycles and progressively weaken the fibers they form.

    Rests on: The preceding question leaves room for a limitation that attachment repair cannot remove. The endpoint supplies a physical basis: a borrowed model in which local force changes the probability of a rare transition out of a folded state.

    Assumption

    Applying that model to skin assumes that the relevant molecular transitions follow its conditions and that unfolded regions persist long enough to become the main remaining limitation. The proposal explicitly makes the model' applicability subject to experimental testing.

What is carried, and what is not. Two screened sources provide relevant partial support: S4, in Biophysical Journal in 2016, places the initial response to lengthwise loading at I fiber surfaces or interfaces, without establishing persistent under repeated in skin; S8, in Molecular Therapy in 2009, reports improved mechanical resistance after restoration in mice, without establishing the proposed deeper damage mechanism. Neither establishes the sequence from uneven molecular forces through lasting to repeated-load failure after attachment repair.S4S8

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The goal does not itself establish that coordinating repair with renewed loading is a limiting factor in middle-aged skin.
  • Hypothesis. Applying that model to skin assumes that the relevant molecular transitions follow its conditions and that unfolded regions persist long enough to become the main remaining limitation. The proposal explicitly makes the model' applicability subject to experimental testing.
How a result here could mislead · 3
  • Different fluctuations in externally applied force could be credited with changing molecular even if the samples actually differ in peak force, local stretching, or , meaning energy transferred by force during movement. External force also does not directly reveal the force on an individual molecule. What closes it: The proposed measurements of peak force, local stretching, and must accompany the matched average force and duration. The model translating tissue loads into molecular forces requires independent calibration, and predictions must be fixed before testing new loading sequences.
  • A signal from a , a molecule that binds unfolded , could be read as evidence that persistent I or III damage caused failure when it instead detects another type or damage produced after cells contract. What closes it: The signal must be located in the supporting skin layer and assigned to types, as the proposal requires. Measurements must resolve its timing relative to contraction and visible tearing and establish persistence between cycles; binding alone does not establish those properties.
  • Continued failure after suppressing , a force-sensitive channel that allows calcium into cells, could appear to exclude the rival explanation even if suppression did not stop the downstream cell contraction. Failure in tissue with cells removed could instead reflect mechanical changes caused by their removal. What closes it: Suppression must be shown to reduce the contraction relevant to the rival mechanism. The cell-removal comparison must verify preservation of the original mechanical behavior, a control the proposal explicitly requires.

What would make this wrong. Rapid restoration of repeated-load tolerance solely by suppressing , while the measured molecular damage remains unchanged, would contradict persistent as the main remaining limitation. That observation would not establish that never occurs; it would break the claim that it controls the failure being explained.

What it would change. If this mechanism held, restoring attachments between skin layers would leave a separate molecular source of repeated damage, so work toward youthful skin function would also have to address that source. A closed wound and restored would be insufficient evidence of restored load tolerance. Even then, the supplied material would not establish a treatment that restores the broader functional condition of middle-aged human skin; it provides neither such an outcome nor a definition of , the endpoint named in the proposal.

Sources read · 7

4 literature searches, 5 full texts, 5 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1BackgroundAbstract only

Collagen Nanoyarns: Hierarchical Three-Dimensional Biomaterial Constructs. · Biomacromolecules · 2023

“Structural denaturation assessment of native collagen using circular dichroism (CD) spectroscopy showed that 60% of the triple-helical collagen content in CNYs was retained.”

Does not settle: Источник не исследует дермальный коллаген III, якорные фибриллы, повторный сдвиг, необратимое разворачивание между циклами, неоднородность нагрузки или изменение несущей способности волокон после восстановления.

S2BackgroundAbstract only

Recombinant expression and functional characterization of human collagen III fragments. · International journal of biological macromolecules · 2026

“These fragments self-assembled into triple helix structures with an untwisting temperature of 25 °C and subsequently formed nanofibers.”

Does not settle: Источник не устанавливает необратимость разворачивания коллагена I или III, его накопление при повторном сдвиге, распределение нагрузки в дермальных волокнах, связь с несущей способностью или влияние восстановления якорных фибрилл.

S3BackgroundAbstract only

Novel polycaprolactone (PCL)-type I collagen core-shell electrospun nanofibers for wound healing applications. · Journal of biomedical materials research. Part B, Applied biomaterials · 2023

“Using this strategy, the triple helix structure characteristic of the collagen molecule was preserved.”

Does not settle: Источник не устанавливает влияние повторного сдвига, необратимого разворачивания коллагена I или III, неоднородности нагрузки, снижения несущей способности волокон или восстановления якорных фибрилл.

S4Background

Nanomechanics of Type I Collagen. · Biophysical journal · 2016

“It is not the fibril core that yields initially to axial stress. Rather, it must be the portion of the fibril exposed to the solvent and/or the fibril-fibril interface that bears the initial strain.”

Does not settle: Источник не изучает повторный сдвиг, необратимое разворачивание тройных спиралей, накопление повреждений между циклами, коллаген III, дерму, якорные фибриллы или SPV_3.

S5BackgroundAbstract only

A review of the effects of ageing on skin integrity and wound healing. · British journal of community nursing · 2019

“In particular, the dermoepidermal junction becomes flattened, which predisposes the tissue to shear and friction forces.”

Does not settle: The abstract does not establish irreversible unfolding of collagen I or III triple helices, heterogeneous load concentration, persistence of unfolded regions between cycles, repeated-shear tolerance after collagen VII repair, or any effect on SPV_3.

S7Background

The Infuence of Salicin on Rheological and Film-Forming Properties of Collagen. · Molecules (Basel, Switzerland) · 2021

“The rheological properties of collagen solutions with and without salicin were characterized by steady shear tests.”

Does not settle: Источник не исследует дермальный коллаген I или III, якорные фибриллы, повторный сдвиг, необратимое разворачивание тройных спиралей, накопление повреждений между циклами или SPV_3.

S8Partly answers it

Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. · Molecular therapy : the journal of the American Society of Gene Therapy · 2009

“Although the active biosynthesis lasted <28 days, collagen VII remained stable and dramatically improved skin integrity and resistance to mechanical forces for at least 100 days, as measured with a digital 3D-skin sensor for shear forces.”

Does not settle: Источник показывает улучшение устойчивости кожи к сдвиговым силам после частичного восстановления коллагена VII у мышей, но не устанавливает роль необратимого разворачивания тройных спиралей коллагена I или III, неоднородности нагрузки, накопления повреждений между циклами или SPV_3.

The gap this hypothesis explains

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Would unchanged resistance to repeated sliding forces after restoring skin’ anchoring fibres disprove their role as its main recovery limit?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Если восстановление зрелых до молодого диапазона не улучшит , опровергнет ли это их роль главного ограничения восстановления возрастной кожи после закрытия повреждения?

What this question is asking

The question concerns whether rebuilding the structures that hold skin layers together would restore strength after an injury has closed in older skin. It asks about restoring mature made from to the range found in young skin, then comparing resistance to repeated sliding forces with resistance before restoration or without it. If resistance does not improve, it asks whether that result would refute the idea that these fibres are the main remaining constraint on recovery. The question treats that limiting role as a possibility, while the supplied background points to inherited deficiency as supporting evidence whose relevance to ordinary ageing remains unestablished.

What the terms mean
Collagen VII
A structural protein that is a main component of the fibres attaching adjacent skin layers. The question concerns whether restoring structures made from this protein restores mechanical function.
Protein
A biological molecule that can provide structure or perform work in cells and tissues. Collagen VII has a structural role in this question.
Anchoring fibrils
Fine attachment fibres that help hold the outer skin layer to the tissue beneath it. Their presence, maturity and ability to carry forces are related properties, but the supplied material does not establish that measuring one proves the others.
Mature anchoring fibrils
Anchoring fibres described as having reached their fully formed state. The supplied input gives no measurement rule for confirming that state.
Young range
The range of a specified measurement found in young comparison skin. The input does not specify the measurement, reference population or boundaries of that range.
Repeated shear
Repeated forces that tend to slide neighbouring layers past one another. Resistance to these forces is the functional outcome in the question.
Friction
Resistance when contacting surfaces rub or try to slide against one another. Friction-related blistering in the sources is relevant background, but is not the specified test of resistance to repeated .
Injury closure
The stage when an injury is no longer open at the surface. The question distinguishes this stage from recovery of the skin’ ability to withstand repeated forces.
Mechanical recovery or readiness
Recovery of the ability to tolerate physical loading. Here the intended measure is resistance to repeated sliding forces, although the input gives no operational threshold.
Main constraint
The factor proposed to place the strongest limit on recovery under the conditions being considered. Being necessary for normal skin attachment does not by itself establish being the main constraint on recovery in ageing.
Sufficiency
Whether restoring the specified factor is enough to produce the stated functional improvement under the relevant conditions. This differs from whether that factor contributes to normal function.
Inherited collagen VII deficiency
A condition present because inherited genetic changes leave absent or defective. The supplied disease evidence concerns this setting rather than ordinary age-related changes.
Gene and gene therapy
A gene contains biological instructions for making a product such as a protein. The gene therapy described in S6 delivers the gene for with the aim of restoring that protein.
Collagen VII processing and deposition
Processing refers to changes made to the protein as it is prepared for its role; deposition refers to its placement in tissue. S10 reports on these properties, which do not by themselves confirm mature anchoring-fibril function.
Protein-cutting enzymes
Proteins that cut other proteins and can help prepare them for their roles. S10 concerns loss of activity of one such group and reports that processing nevertheless remained unaffected.
Dense layer of the skin’s supporting boundary
A compact layer within the thin supporting structure between the outer skin and the underlying tissue. S4 locates blister separation beneath this layer.
What the question takes for granted
Premise only partly supported
Mature may be the main constraint on recovery of aged skin after injury closure, such that restoring them to a young range should improve resistance to repeated .

Collagen VII is a structural protein in fibres that help fasten the outer skin layer to the tissue underneath. The proposed assumption is that insufficient fully formed fibres are the chief reason older skin remains mechanically vulnerable after its surface closes. If that held, rebuilding those fibres to a youthful level would be expected to improve resistance to repeated sliding forces.

The read sources support the narrower claim that these anchoring structures contribute to attachment between skin layers: S3 describes severe fragility when they are absent, and S8 and S9 connect defective with loss of attachment. They do not establish that these structures are the main recovery constraint in ordinary ageing, that restoration to a young range is sufficient, or that unchanged resistance would refute their main limiting role. S10 further describes skin and healing abnormalities without detected changes in processing or deposition, although those measurements do not establish the condition of mature .S3S8S9S10

The same question asked without the part nothing read establishes:

  • In aged skin after injury closure, what would unchanged resistance to repeated sliding forces after confirmed restoration of mature establish about their contribution to recovery?
  • Does restoring mature to a young range improve resistance to repeated sliding forces in aged skin after injury closure?
What turns on the answer
  • Unchanged resistance refutes the main-constraint claim This interpretation depends on the claim predicting that confirmed restoration of mature anchors, under the relevant conditions, must improve resistance. If restoration occurred and the predicted improvement did not, the result would count against that sufficiency claim. It would not by itself erase the anchors’ contribution to keeping skin layers attached.
  • Unchanged resistance leaves the main-constraint claim unresolved If the claim allows recovery to depend on additional conditions, unchanged resistance after restoring the anchors would not uniquely identify which condition still limits function. Structural restoration would then be insufficient to establish mechanical recovery, but the result alone would not rank the remaining constraints. The supplied sources do not establish which interpretation applies to aged skin.
Why it matters

Skin layers need to remain attached when forces try to slide them against one another; the supplied sources connect defective anchoring structures with friction-related blistering in inherited disease (S3, S4, S8, S9). The proposed explanation extends that connection to older skin after an injury closes: restoring the anchors would remove the main obstacle to mechanical recovery. If that explanation were sufficient, structural restoration would be expected to improve resistance to repeated loading. Treating restoration alone as proof of recovered strength could therefore overstate recovery, while treating unchanged strength as proof that the anchors have no role would confuse their contribution with their ability to restore function on their own.

What is already established

имеет доказательства при ; достаточность его восстановления при обычном старении и повторных нагрузках не установлена.

What would have to be true

Механическая готовность должна достигаться в молодой срок; ранний функциональный сигнал должен выявлять остаточную уязвимость до повторного повреждения.

What is missing

Нужно проверить, улучшает ли подтверждённое восстановление якорных структур реальную устойчивость и позволяет ли оно исключить скрытые механизмы повреждения.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Проверяемая гипотеза: после восстановления ограничивают редкие необратимые переходы в . Неоднородное создаёт участки с высокой вероятностью такого перехода даже при приемлемой . Развёрнутые молекулярные участки сохраняются между циклами и постепенно уменьшают . Восстановление оставляет этот механизм действующим. Снижение вероятности должно стабилизировать .

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

и : =·(f·/(·T)); =(−∫₀ᵗ k()ds). Здесь означает частоту разворачивания одного уязвимого участка ; означает её значение без приложенной силы; означает локальную на этом участке в момент ; означает расстояние до вдоль ; означает ; T означает ткани; t означает длительность испытания; означает вероятность отсутствия перехода за это время. Для случайных историй силы наблюдаемая вероятность равна среднему по этим историям. При быстро меняющихся приблизительно со средним и средняя частота равна ·(·/(·T)+(·)²/(2(·T)²)). и характеризуют именно локальную молекулярную силу. Приближение применимо при сохранённом и редких переходах; его пригодность для кожи проверяется экспериментально. Источник принципа: [Крамерс, 1940](https://www.mit.edu/~kardar/research/seminars/translocation/Kramers1940.pdf).

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

После восстановления сравнить повторные с одинаковой средней силой и длительностью, но разной . Отдельно регистрировать , и . Модель должна заранее предсказать вероятность первого молекулярного повреждения по полной и затем выдержать проверку на новых последовательностях. должно предшествовать и видимому разрыву, сохраняться при подавлении и воспроизводиться в выделенном . Быстрое восстановление переносимости исключительно после подавления при неизменном молекулярном повреждении противоречит этой гипотезе как объяснению главного ограничения.

Would tell it apart from at least one rival. The prediction specifies measurable temporal ordering, persistence under PIEZO1 suppression, reproduction in isolated dermal matrix, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Доступны и , связывающиеся с развёрнутым . Последовательные позволяют оценить молекулярное повреждение до . необходимо локализовать в и сопоставить с типами . Силу на отдельной молекуле непосредственно из внешней силы получить нельзя: модель требует независимой . также требует контроля сохранности исходной механики.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

После восстановления сравнить повторные с одинаковой средней силой и длительностью, но разной . Отдельно регистрировать , и . Модель должна заранее предсказать вероятность первого молекулярного повреждения по полной и затем выдержать проверку на новых последовательностях. должно предшествовать и видимому разрыву, сохраняться при подавлении и воспроизводиться в выделенном . Быстрое восстановление переносимости исключительно после подавления при неизменном молекулярном повреждении противоречит этой гипотезе как объяснению главного ограничения.

  • What would separate them

    Restored skin anchors may trigger cell contraction that reopens healed wounds predicts: В доноров 40–60 лет провести восстановления и подавления , включаемого только после одинакового закрытия повреждения. Гипотеза предсказывает : восстановление при активном оставляет прежней или ухудшает её, а последующее подавление быстро увеличивает число циклов до повреждения. Перед первым повреждением должны возникать и ; сигнал появляется позднее. Возвращение функционального в экспериментальную модель восстанавливает уязвимость. Отсутствие такого эффекта при подтверждённом подавлении и сохранённой опровергает гипотезу.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.